Polyplex Corporation Limited

rs,

February 15, 2022 The General Manager - Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 SYMBOL : POLYPLEX BSE Scrip Code : 524051 Dear Sir(s), Sub: R

233 million

& Research IND AA- (Stable Outlook) Q3 FY 21-22 Highlights YTD FY 21-22 Highlights 1,746 Cr ($ 233 million) Sales Revenue# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY

50 million

Q3 FY 21-22 Highlights YTD FY 21-22 Highlights 1,746 Cr ($ 233 million) Sales Revenue# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Reven

13%

-22 Highlights 1,746 Cr ($ 233 million) Sales Revenue# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million

42%

hts 1,746 Cr ($ 233 million) Sales Revenue# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalize

37%

Cr ($ 233 million) Sales Revenue# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalized EBITDA*

8%

million) Sales Revenue# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalized EBITDA* +31% YoY

636 million

e# 372 Cr ($ 50 million) Normalized EBITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalized EBITDA* +31% YoY -1% YoY # Excludes other op

131 million

ITDA* +13% QoQ +42% YoY +37% QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalized EBITDA* +31% YoY -1% YoY # Excludes other operating revenues * Normalised EBITDA: E

31%

QoQ +8% YoY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalized EBITDA* +31% YoY -1% YoY # Excludes other operating revenues * Normalised EBITDA: EBITDA excluding impact of

1%

oY 4,726 Cr ($ 636 million) Sales Revenue# 973 Cr ($ 131 million) Normalized EBITDA* +31% YoY -1% YoY # Excludes other operating revenues * Normalised EBITDA: EBITDA excluding impact of unrealised

51%

Mix (YTD FY 21-22) Polyplex Group Structure^ America Europe Other Asia India RoW PCL (India)* 51% PTL (Thailand) 100% 100% 100% PE (Turkey) PU (USA) PFI (Indonesia) * Including Holding of S

“These are based on certain assumptions as on date and are subject to significant risks and uncertainties, as they could be substantially influenced by several factors which are beyond Company’s control including, but not limited to, fluctuations in foreign exchange rates, changes in key raw material prices, changes in market dynamics, impact of consolidation of subsidiaries and any unexpected production down times due to machinery breakdown, unforeseen delays in project start up etc.”

Note

2

Notes

2

Note

• Industry CUF as per CY, Polyplex CUF as per FY (YTD Q3 for FY’2021-22) • Industry CUF is based on internal estimates. !11 80%82%82%80%74%100%99%100%99%95%2,28,7882,03,4811,84,3001,76,74274%80%82%82%80%95%99%100%99%100%1,74,847 Strong financial & operational track record !12 Q3 FY 21-22 Performance Snapshot QoQ Growth (Q3 FY 21-22 v/s Q2 FY 21-22) YoY Growth (Q3 FY 21-22 v/s Q3 FY 20-21) Sales Volume (All Films) 83,638 MT Sales Revenue# 1,746 INR Crores ($ 233 million) Normalized EBITDA* 372 INR Crores ($ 50 million) PAT (Before Minority) 305 INR Crores ($ 41 million) EPS 55.89 INR/Share

Notes

• Factors impacting EBITDA (QoQ and YoY): ✦ Consolidation impact of FX fluctuation on change in stock ✦ Higher volumes supplemented by start up of BOPP line in Indonesia • Factors impacting reported PAT & EPS (YoY) 7% 13% 37% 80% 83% 4% 42% 8% 36% 34% ✦ In Q3 2021-22, there is an unrealised FX gain of INR 65.39 crores ($ 8.73 million) as against unrealised FX gain of INR 0.11 crores ($ 0.01 million) in Q3 2020-21 on account of re- statement of foreign currency long term loans # Excludes other operating revenues * Normalised EBITDA: EBITDA excluding impact of unrealised FX gains / (losses) on long term loans !13 YTD FY 21-22 Performance Snapshot YoY Growth (YTD FY 21-22 v/s YTD FY 20-21) Sales Volume (All Films) 238,592 MT Sales Revenue# 4,726 INR Crores ($ 636 million) Normalized EBITDA* 973 INR Crores ($ 131 million) PAT (Before Minority) 660 INR Crores ($ 89 million) EPS 122.01 INR/Share

Notes

• Factors impacting EBITDA: ✦ Consolidation impact of FX fluctuation on change in stock • Factors impacting reported PAT & EPS 4% 31% -1% 1% -1% ✦ In YTD 2021-22, there is an unrealised FX gain of INR 23.09 crores ($ 3.11 million) as against unrealised FX loss of INR 24.98 crores ($ 3.34 million) in YTD 2020-21 on account of re- statement of foreign currency long term loans # Excludes other operating revenues * Normalised EBITDA: EBITDA excluding impact of unrealised FX gains / (losses) on long term loans !14 Thin PET Film - Trend Thin PET Film* Sales Volume (MT) Ex-Factory Price - Thin PET Film* (USD/Kg) Value Addition** - Thin PET Film* (USD/Kg) Q3 Q2 Q1 17-18 18-19 19-20 20-21 YTD 21-22 Annualised * Includes : 17-18 18-19 19-20 20-21 Q1 21-22 Q2 21-22 Q3 21-22 - film transferred to Silicone Coating & Extrusion Coating lines but excludes sales of final product from these lines - volume of value added films - Metallized, Holography, General purpose offline coated, Transfer Metallized Paper

Note

• Dividend considered based on the payout dates • The returns have been calculated based on the stock price data as on 09th Feb 2022 !20 1,0569909528507813,2323,0533,0292,7712,5487818509529901,056 Fourth Quarter 21-22 Guidance Q1 19-20 Q2 19-20 Q3 19-20 Q4 19-20 Q1 20-21 Q2 20-21 Q3 20-21 Q4 20-21 Q1 21-22 Q2 21-22 Q3 21-22 Q4 21-22 Normalised EBITDA (USD million) The forward-looking statements reflect Polyplex’s expectations of its next quarter earnings. These are based on certain assumptions as on date and are subject to significant risks and uncertainties, as they could be substantially influenced by several factors which are beyond Company’s control including, but not limited to, fluctuations in foreign exchange rates, changes in key raw material prices, changes in market dynamics, impact of consolidation of subsidiaries and any unexpected production down times due to machinery breakdown, unforeseen delays in project start up etc. The Company does not make any representation, warranty